Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients [Phase 3]
Phase 3 trial assessing the effect of tiotropium inhalation capsules (Spiriva) on exercise tolerance in COPD patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma [Phase 4]
Phase 4 trial update evaluating efficacy and safety of tiotropium in COPD patients with comorbid asthma.
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Dose Finding Study in COPD [Phase 2]
Phase 2 dose-finding study in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-26Clinical Trial Update: Efficacy and Safety Study of QVA149 in COPD Patients [Phase 3]
Phase 3 trial update on the efficacy and safety of QVA149 in COPD patients has completed with results posted.
-
FDA approval · 2017-12-20FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) from GlaxoSmithKline LLC, resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-20FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA, a fixed-dose inhaled corticosteroid/long-acting beta-agonist from Organon LLC.
-
FDA approval · 2017-12-20FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for the Fluticasone Propionate and Salmeterol combination by Teva, resulting in updated labeling…
-
FDA approval · 2017-12-20FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for the fixed-dose inhaled combination budesonide and formoterol fumarate dihydrate from AstraZeneca…
-
FDA approval · 2017-12-20FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA (fluticasone furoate and vilanterol) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Supplemental Selenium and Vitamin E and Pulmonary Function [Phase 3]
A Phase 3 trial assessing selenium and vitamin E supplementation and pulmonary function in chronic obstructive pulmonary disease has complet…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD [Phase 4]
Phase 4 trial evaluating tolerability of metoprolol-succinate-ER and carvedilol in patients with chronic obstructive pulmonary disease and a…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Obstructive Airways Diseases in Emergency Department (OADED) Study
The OADED study evaluating obstructive airway diseases in emergency departments has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
A completed University of Arizona study reporting on inflammatory biomarkers associated with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS research · 2017-12-04Clinical Trial Update: GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries [NA]
Clinical trial update on GECo examining the implementation and effectiveness of COPD self-management action plans in low- and middle-income …
-
CLINICAL_TRIALS research · 2017-11-28Clinical Trial Update: Analysis With Clusters of QUAntitative Tomodensitometric Vascular, bronchIal and Parenchymal Pulmonary Parameters for COPD Patients
Clinical trial update describing an analysis using clusters of quantitative tomodensitometric vascular, bronchial, and parenchymal pulmonary…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Educational Interventions for Chronic Obstructive Pulmonary Disease (COPD) Self-management in Ethno-cultural Communities [NA]
Clinical trial update describing educational interventions to improve self-management of Chronic Obstructive Pulmonary Disease in ethnocultu…
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating adipose-derived stem cells for chronic obstructive pulmonary disease was withdrawn; no results are rep…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Nebulized Hypertonic Saline for Inpatient Use in COPD [Phase 4]
Phase 4 trial update reporting results for nebulized hypertonic saline used in hospitalized patients with chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Pneumological Acute Coronary Syndrom (ACS) Phenotyping Aachen
The clinical trial NCT02587481 completed a study on phenotyping pneumological acute coronary syndrome in Aachen.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Muscle Activity and Sensation During Upright Partitioned Leg Exercise in COPD [NA]
A completed clinical trial update examining muscle activity and sensation during upright partitioned leg exercise in individuals with chroni…
-
CLINICAL_TRIALS research · 2017-11-20Clinical Trial Update: High Flow Nasal Cannula and Aerobic Capacity Training [NA]
This clinical trial update reports on a COPD study evaluating the combination of high flow nasal cannula therapy with aerobic capacity train…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Respiration Rate Monitoring in COPD Patients [NA]
A completed clinical trial evaluating respiration rate monitoring in patients with Chronic Obstructive Pulmonary Disease conducted with ResM…
-
FDA approval · 2017-11-16FDA Approved: BUDESONIDE INHALATION SUSPENSION — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s original application for Budesonide Inhalation Suspension, a generic inhaled corticosteroid, for maintenance t…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD Patients [NA]
A completed clinical trial evaluated whether non-invasive ventilation improves oxygenation of peripheral muscle in patients with hypercapnic…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Evaluation of FeNO During and Following Acute COPD Exacerbation
A study evaluating exhaled nitric oxide (FeNO) during and after acute COPD exacerbations was terminated.